Ming-Dong Zhang

Ming-Dong Zhang

Auto-generated profile, based on publicly available information

Ming-Dong Zhang

Department of Medical Biochemistry and Biophysics, Division of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2016 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RRRoman A. Romanov
Roman A. Romanov
AZAmit Zeisel
Amit Zeisel
JBJoanne Bakker
Joanne Bakker
FGFatima Girach
Fatima Girach
Arash HellysazArash Hellysaz
Arash Hellysaz
THTibor Harkany
Tibor Harkany

16 August 2019 in Science
Verified
Journal Article
Closed access
PDF file
HAHind Abdo
Hind Abdo
LCLaura Calvo-Enrique
Laura Calvo-Enrique
JLJose Martinez Lopez
Jose Martinez Lopez
JSJianren Song
Jianren Song
MZMing-Dong Zhang
Ming-Dong Zhang
PEPatrik Ernfors
Patrik Ernfors
A newly discovered cell type for pain perception: Pain has been thought to be initiated by activation of free nerve endings without end organs in the skin. In contrast to this paradigm, Abdo et al. discovered a previously unknown meshlike organ covering the skin that senses dangerous environmental stimuli (see the Perspective by Doan and Monk). This organ is built from specialized glial cells located in the epidermal-dermal border and is sufficient and required for initiation of mechanical pain transduction. Science , this issue p. 695 ; see also p. 641

16 June 2017 in Science
Verified
Journal Article
Closed access
PDF file
CPChanggeng Peng
Changgeng Peng
LLLili Li
Lili Li
MZMing-Dong Zhang
Ming-Dong Zhang
CGCarolina Bengtsson Gonzales
Carolina Bengtsson Gonzales
MPMarc Parisien
Marc Parisien
PEPatrik Ernfors
Patrik Ernfors
Nociception is protective and prevents tissue damage but can also facilitate chronic pain. Whether a general principle governs these two types of pain is unknown. Here, we show that both basal mechanical and neuropathic pain are controlled by the microRNA-183 (miR-183) cluster in mice. This single cluster controls more than 80% of neuropathic pain–regulated genes and scales basal mechanical sensitivity and mechanical allodynia by regulating auxiliary voltage-gated calcium channel subunits α2δ-1 and α2δ-2. Basal sensitivity is controlled in nociceptors, and allodynia involves TrkB+ light-touch mechanoreceptors. These light-touch–sensitive neurons, which normally do not elicit pain, produce pain during neuropathy that is reversed by gabapentin. Thus, a single microRNA cluster continuously scales acute noxious mechanical sensitivity in nociceptive neurons and suppresses neuropathic pain transduction in a specific, light-touch–sensitive neuronal type recruited during mechanical allodynia.

27 November 2014 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RRRoman A. Romanov
Roman A. Romanov
AAAlan Alpar
Alan Alpar
MZMing‐Dong Zhang
Ming‐Dong Zhang
AZAmit Zeisel
Amit Zeisel
ACAndré Calas
André Calas
THTibor Harkany
Tibor Harkany
A hierarchical hormonal cascade along the hypothalamic‐pituitary‐adrenal axis orchestrates bodily responses to stress. Although corticotropin‐releasing hormone (CRH), produced by parvocellular neurons of the hypothalamic paraventricular nucleus (PVN) and released into the portal circulation at the median eminence, is known to prime downstream hormone release, the molecular mechanism regulating phasic CRH release remains poorly understood. Here, we find a cohort of parvocellular cells interspersed with magnocellular PVN neurons expressing secretagogin. Single‐cell transcriptome analysis combined with protein interactome profiling identifies secretagogin neurons as a distinct CRH‐releasing neuron population reliant on secretagogin9s Ca2+ sensor properties and protein interactions with the vesicular traffic and exocytosis release machineries to liberate this key hypothalamic releasing hormone. Pharmacological tools combined with RNA interference demonstrate that secretagogin9s loss of function occludes adrenocorticotropic hormone release from the pituitary and lowers peripheral corticosterone levels in response to acute stress. Cumulatively, these data define a novel secretagogin neuronal locus and molecular axis underpinning stress responsiveness. Synopsis Bodily responses to acute stress are orchestrated by the hierarchical release of stress hormones along the hypothalamic‐pituitary‐adrenal axis. Corticotropin‐releasing hormone (CRH)‐secreting neurons in the paraventricular nucleus of the hypothalamus are first order neurons in this axis, priming subsequent hormonal cascades upon CRH release into the portal circulation at the median eminence. Secretagogin is identified as the first neuronal Ca2+ sensor localized to parvocellular systems. The transcriptome landscape of a novel hypothalamic neuron subtype, which contains secretagogin as Ca2+ sensor, is shown. Secretagogin9s Ca2+‐dependent protein interactome minimally required for regulated CRH release is defined. Secretagogin is recognized to rate‐limit CRH release, thus limiting hormonal responses to stress.

14 December 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CTChiara Tesoriero
Chiara Tesoriero
ACAlina Codita
Alina Codita
MZMing-Dong Zhang
Ming-Dong Zhang
ACAndrij Cherninsky
Andrij Cherninsky
HKHåkan Karlsson
Håkan Karlsson
KKKrister Kristensson
Krister Kristensson
An increased incidence in the sleep-disorder narcolepsy has been associated with the 2009–2010 pandemic of H1N1 influenza virus in China and with mass vaccination campaigns against influenza during the pandemic in Finland and Sweden. Pathogenetic mechanisms of narcolepsy have so far mainly focused on autoimmunity. We here tested an alternative working hypothesis involving a direct role of influenza virus infection in the pathogenesis of narcolepsy in susceptible subjects. We show that infection with H1N1 influenza virus in mice that lack B and T cells (Recombinant activating gene 1-deficient mice) can lead to narcoleptic-like sleep–wake fragmentation and sleep structure alterations. Interestingly, the infection targeted brainstem and hypothalamic neurons, including orexin/hypocretin-producing neurons that regulate sleep–wake stability and are affected in narcolepsy. Because changes occurred in the absence of adaptive autoimmune responses, the findings show that brain infections with H1N1 virus have the potential to cause per se narcoleptic-like sleep disruption.

22 January 2021 in Pain
Verified
Journal Article
Open access
PRPuneet Rinwa
Puneet Rinwa
LCLaura Calvo-Enrique
Laura Calvo-Enrique
MZMing-Dong Zhang
Ming-Dong Zhang
JNJens Randel Nyengaard
Jens Randel Nyengaard
PKPáll Karlsson
Páll Karlsson
PEPatrik Ernfors
Patrik Ernfors
Recent findings indicate that nociceptive nerves are not “free”, but similar to touch and pressure sensitive nerves, terminate in an end-organ in mice. This sensory structure consists of the nociceptive nerves and specialized nociceptive Schwann cells forming a mesh-like organ in subepidermis with pain transduction initiated at both these cellular constituents. The intimate relation of nociceptive nerves with nociceptive Schwann cells in mice raises the question whether defects in nociceptive Schwann cells can by itself contribute to pain hyperalgesia, nerve retraction, and peripheral neuropathy. We therefore examined the existence of nociceptive Schwann cells in human skin and their possible contribution to neuropathy and pain hyperalgesia in mouse models. Similar to mouse, human skin contains SOX10+/S100B+/AQP1+ Schwann cells in the subepidermal border that have extensive processes, which are intimately associated with nociceptive nerves projecting into epidermis. The ablation of nociceptive Schwann cells in mice resulted in nerve retraction and mechanical, cold, and heat hyperalgesia. Conversely, ablating the nociceptive nerves led to a retraction of epidermal Schwann cell processes, changes in nociceptive Schwann cell soma morphology, heat analgesia, and mechanical hyperalgesia. Our results provide evidence for a nociceptive sensory end-organ in the human skin and using animal models highlight the interdependence of the nerve and the nociceptive Schwann cell. Finally, we show that demise of nociceptive Schwann cells is sufficient to cause neuropathic-like pain in the mouse.